Participants 50 63 4
COPD patients
Participants 259 320 4
subjects with COPD who were participating in a clinical trial
Participants 523 657 4
placebo-controlled clinical trial of triamcinolone acetonide (1200 microg daily) vs placebo in participants with mild-to-moderate COPD
Participants 757 814 3
1,116 participants in 10 centers over > 3.5 to 4.5 years.
Participants 828 965 6
A total of 1,116 smokers or recent ex-smokers with mild-to-moderate COPD (age range, 40 to 69 years; mean age, 56.3 years; 37.2% female).
